Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC)
0.1.20 - Build CI United States of America flag

Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions

Artifacts Summary

This page provides a list of the FHIR artifacts defined as part of this implementation guide.

Structures: Abstract Profiles

These are profiles on resources or data types that describe patterns used by other profiles, but cannot be instantiated directly. I.e. instances can conform to profiles based on these abstract profiles, but do not declare conformance to the abstract profiles themselves.

Manufacturing and/or Test Site Organization

A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances.

Sponsor Organization

A profile for the data elements required to identify the sponsor of the drug products or substances.

Supplier Organization

A profile for the data elements required to identify an organization that supplies drug products or substances.

Structures: Resource Profiles

These define constraints on FHIR resources for systems conforming to this implementation guide.

CMC eCTD 32P10 Document

Definition for a document bundle with the CMC eCTD 32P10 profiles.

CMC eCTD 32S10 Document

Definition for a document bundle with the CMC eCTD 32S1 profiles.

CMC eCTD 32S23 Document

Definition for a document bundle with the CMC eCTD 32S23 profiles.

CMC eCTD SP4151 Document

Definition for a document bundle with the CMC eCTD SP4151 profiles.

Component Substance

Any raw material intended for use in the manufacture of a drug substance, or any ingredient intended for use in the manufacture of a drug product including those that may not appear in such drug product.

Document Reference Attachment

A profile that represents the document or diagram in base64.

Drug Product Component

The amount details about the drug product components to define the product composition in a product unit. Use composition.

Drug Product Container Closure

Description and coding of the container closure system. Profile of Drug Product profile.

Drug Product Description

Includes the properties of the drug product and components. Profile of Drug Product profile.

Excipient Drug Substance

Provides sufficient information to identify an inactive substance and raw materials and its source when stability data is required in the submission.

Manufactured Drug Product

The manufactured drug product defined by all its parts or layers. If the drug product composition is homogeneous it will have a single part or component.

Polymorphic Form

Alternate structure present in the drug substance

Quality Specification

A quality specification is for a drug product or drug substance (excipient, API or raw material).

Routine Drug Product

Includes the identifying information of the drug product. Profile of Drug Product profile.

Routine Drug Substance

Provides sufficient information to identify a drug substance. Profile on Drug Substance profile.

Substance General Information

Substance General Information containting Drug Substance (Active Ingredient) nomenclature (2.3.S.1.1) and Substance Structure (2.3.S.1.2) profile.

eCTD Product Description and Composition

The fields needed to represent the Product Description, Container Closure and Composition of the Drug Product to be included under the 3.2.P.1.0 heading of the eCTD. References Sponsor Organization, Drug Product Description, and Product Container Closure System.

eCTD Specification Composition

The fields needed to Quality Specifications for APIs, Drug Substances, Excipients and Raw Materials.

eCTD Substance Control of Materials Composition

The fields needed to represent the Substance Control of Materials to be included under the eCTD 3.2.S.2.3 heading. References Sponsor Organization and Drug Substance Materials.

eCTD Substance General Information

The fields needed to represent the Substance Nomenclature and Structure to be included under the 3.2.S.1 heading of the eCTD. References Sponsor Organization.

Structures: Data Type Profiles

These define constraints on FHIR data types for systems conforming to this implementation guide.

PqAddress

pq-specific Constraints on the Address datatype dealing with US addresses.

Structures: Extension Definitions

These define constraints on FHIR data types for systems conforming to this implementation guide.

Additional Information

Any additional information

Container Closure

The packaging information including a brief description of the components, the assembled packaging system and any precautions needed to ensure the protection and preservation of the drug substance or drug product during their use in the clinical trials.

Content Percent

constituent content percent

Hierarchical Level

Numeric level in the hierarchical value-set

Interpretation Code

A code that describes how to relate the given value to an acceptance value.

Optional Denominator

The constituent optional denominator is used then the unit is other than 1 per product part.

Profile IG Version

The IG version number of the bundle profile to which the instance conforms. Additionally, all the profiles of the resources in the bundle must conform to this version.

Specification Type

A classification of specification related to the kind of the entity it is referencing.

Strength Extension

Values required in Ingredient.substance.strength

Test Order | Stage Sequence Order

The sequential number assigned to each Test or Stage to specify the order of display on the Quality Specification.

Terminology: Value Sets

These define sets of codes used by systems conforming to this implementation guide.

Chemical Structure Data File Type Terminology

Terminology used to qualify the information pertaining to chemical structure data file types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Closure Type Terminology

Terminology used to qualify the information pertaining to closure types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Coating Purpose Terminology

A category of terminology used to qualify the information pertaining to the coating purpose in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Code System PQCMC Product Characteristic

Product Characteristic for the characteristic element in ManufacturedItemDefinition for product composition.

Conformance to Criteria Terminology

Terminology used to qualify the information pertaining to conformance to criteria in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Container Type Terminology

Terminology used to qualify the information pertaining to container types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Drug Product Component Function Category Terminology

Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Drug Route Of Administration Terminology

Terminology used for representation of the information on pharmaceutical product route of administration in the framework of the Structured Product Labeling documents.

EVMPD Substance Classification

EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) substance classes

Excipient Function Terminology

Terminology used to qualify the information pertaining to excipient functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

GENC Country Codes

The GENC Standard specifies an information model for representing names and codes of geopolitical entities and administrative subdivisions, with supporting information. A geopolitical entity is a region controlled by a political community having an organized government and possessing internal and external sovereignty, most often as a State but sometimes having a dependent relationship on another political authority, or a special sovereignty status. Geopolitical entities may be divided into administratively subordinate divisions. A GENC code (or, synonymously, an ISO 3166 code element) for a geopolitical entity or administrative subdivision is a unique designation of that concept within a set of similar concepts established by a suitable authority. This information model is based on that of ISO 3166 but extended to capture additional information required by U.S. Government stakeholders.

Interpretation Code Terminology

Terminology used to qualify the information pertaining to numeric interpretation codes, Weight Operator codes and Amount Operator code in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Manufactured Dose Form Terminology

Terminology used to qualify the information pertaining to the manufactured dose form.

Name Part Terminology

Terminology used to qualify the information pertaining to Name Part data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

PQ/CMC Capsule Shell Classification Terminology

A category of terminology used to qualify the information pertaining to the classification of a capsule in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Pharmaceutical Dosage Form Terminology

Terminology used for representation of the information on pharmaceutical product dosage form in the framework of the SPL documents.

Product Name Types Terminology

Local value set of all codes in the Code system.

Product Part Ingredient Physical Location Terminology

A category of terminology used to qualify the information pertaining to the location of an ingredient within a product in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Product Part Type Terminology

A category of terminology used to qualify the information pertaining to the product part type in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Quality Standard Terminology

Terminology used to qualify the information pertaining to quality benchmarks in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Relationship Types Terminology

Local value set of all codes in Relationship Types codes

Release Mechanism Terminology

A category of terminology used to qualify the information pertaining to release mechanism in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Release Profile Terminology

A category of terminology used to qualify the information pertaining to release profile in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Source Type Terminology

Terminology used to qualify the information pertaining to source types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Specification Status Terminology

Terminology used to qualify the information pertaining to specification statuses in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Specification Type Terminology

Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Strength Operator Terminology

Terminology used to qualify the information pertaining to strength operators in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Strength Type Terminology

Terminology used to qualify the information pertaining to strength types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Substance Name Type

Waiting for NCIt codes are added for Product Ingredient Name Type

Test Category Terminology

Terminology used to qualify the information pertaining to test categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Test Method Origin Terminology

Terminology used to qualify the information pertaining to test method origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Test Usage Terminology

Terminology used to qualify the information pertaining to test usage in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Testing Site and Organization Identifier Type Terminology

Terminology used to qualify the information pertaining to the sponsor or testing site unique identifier types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.

Units Of Measure Terminology

Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. Note: Includes SPL Unit of Presentation Terminology

eCTD sections Terminology

Value set of all codes in Code system PQCMC Comp Section Types for bindings that require a value set instead of the code system.

Terminology: Code Systems

These define new code systems used by systems conforming to this implementation guide.

Code System PQCMC Comp Section Types

Classification of a section of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes.

Dummy EMA Codesystem

This is a dummy codesystem representing EMA. It contains all the codes that are usable within the IG. It exists because the publisher previously allowed using value sets from codesystems that it could not find (e.g. https://www.ema.europa.eu). This is no longer the case, so a temp code system must be defined in the IG.

Dummy NCIT Codesystem

This is a dummy codesystem representing NCIt. It contains all the codes that are usable within the IG. It exists solely because NCIt currently cannot be validated against and because https://example.com/ codesystems are not allowed by the validator.

GENC Country Codes

The GENC Standard specifies an information model for representing names and codes of geopolitical entities and administrative subdivisions, with supporting information. A geopolitical entity is a region controlled by a political community having an organized government and possessing internal and external sovereignty, most often as a State but sometimes having a dependent relationship on another political authority, or a special sovereignty status. Geopolitical entities may be divided into administratively subordinate divisions. A GENC code (or, synonymously, an ISO 3166 code element) for a geopolitical entity or administrative subdivision is a unique designation of that concept within a set of similar concepts established by a suitable authority. This information model is based on that of ISO 3166 but extended to capture additional information required by U.S. Government stakeholders.

Hierarchical Test Category Codes

Waiting for NCIt codes to be added; then this may be deleted.

Product Name Types Code Types

IG only code system of all codes in Code system.

Relationship Types Codes

Local value set of all codes in the Relationship Types code system.

Terminology: Concept Maps

These define transformations to convert between codes by systems conforming with this implementation guide.

ISO to GENC Country Code Mapping

Maps between ISO 3166-1-3 and GENC. In 6.0.0, SubstanceDefinition.sourceMaterial.countryOfOrigin is bound to <https://build.fhir.org/valueset-country.html> which is all of ISO 3166 including both 2 and 3 letter codes but should only be GENC.

Example: Example Instances

These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.

A DrugProductContainerClosure

An example of section 3.2.P.1.2 for a multilayer product

A DrugProductDescription for a multilayer product

An example of section 3.2.P.1.1

A FinishedProduct profile based on ManufacturedItemDefinition

An example of section 3.2.P.1.3 for a multilayer product

A quality specification is for a drug product

A quality specification is for a Drug Product

A quality specification is for a drug substance

A quality specification is for an API

Base64 Document Reference - L-thyroxine-3D-structure-CT1000583834.sdf

An attached SDfile. The ASCII file content is attached in base64.

Base64 Document Reference - Levothyroid.png

Base 64 Document - png file

Base64 Document Reference - Monosodium_D-thyroxine_hydrate.png

Monosodium D-thyroxine hydrate.png

Bundle for 3.2.S.1

Bundle containng nomenclature and molecular structure

CMCeCTDDocument32P10 bundle

A bundle for 3.2.P.1.0

Carrageenan specification Example

Example raw material (Carrageenan) specification for CTD 3.2.S.2.3. Raw matrials and Excipients share the same profile but are in different bundles.

Citric acid specification Example

Example raw material (Citric acid) specification for CTD 3.2.S.2.3

Composition ingredient substance indentifying information - Maize starch

An excipient in the two layer tablet

Composition ingredient substance indentifying information - acetaminophen

An API used in two layer table example.

Composition ingredient substance indentifying information - aspirin

API used in two layer table example

Drug Manufacturing Site - Vandechemie

Example of Manufacturing site using the MfgTestSiteOrganization profile - Vandechemie

Drug Substance Nomenclature and Structure

LEVOTHYROXINE SODIUM ANHYDROUS

DrugProductComponent example for an excipient - Maize starch

Strength is captured for all excipients

East-West Manufacturing

Manufacture of Chemicals

EctdComposition32P10 for 2 layer tablet

eCTD Product Description and Composition for the two layer tablet example

Example Composition for CTD 3.2.S.2.3

This composition contains one section with reference to each raw material specification for the drug substance.

Example RoutineSubstanceDefinition

Provides sufficient information to identify a drug substance

Example RoutineSubstanceDefinition for Asprin

Identification of the Drug Substance of the raw materials whose specifications are

Example SubstanceDefinition for Carrageenan

Identification of the subject of the specification which is a sourced plant based raw materials. It contains the sourceMaterial backbone elements.

Example SubstanceDefinition for anhydrous citric acid

Identification of the subject of the specification. It is commonly used in the pharmaceutical industry as a stabilizer and preservative.

Example SubstanceDefinition for water

Identification of the subject of the specification

Example of MfgTestSiteOrganization profile on Organization

A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances.

Example of a Supplier Organization

This example if for a Supplier Organization

FHIR Document example of 3.2.P.4.1.

FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Substance

FHIR Document example of 3.2.P.5.1.

FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Product

IngredComponentSubstance example showing the use of the sourceMaterial backbone element

ComponentSubstance example showing the use use of the sourceMaterial backbone element

Manufacturing Site (J. Jones Research)

Manufacturing site instance of an Organization Example. There will be a type code in future

Polymorphic Form Example

Polymorphic Form - DextroThyroxine

Sponsor of API

SponsorOrganization - Large Life

SponsorOrganization - Wunderwerke

A company sponsor of a drug application

SponsorOrganization J. Jones Research

Example of a Sponsor type of Organization

Strength info for the Active Ingredient

one of the active ingredients in the two layer table example - aspirin

Strength information - Grape skin extract

Example of a DrugProductComponent for an Inactive Ingredient

Strength information for the Active Ingredient - acetaminophen

An active ingredient in the two layer table example - acetaminophen

Vidinaid

Manufacturing site (Vidinaid) instance with second address line

Water Specification Example

Example raw material (water) specification for CTD 3.2.S.2.3

drug product for specification

Includes the identifier of the drug product

eCTD Composition for 3.2.S.1

Composistion containing eCTD Substance General Information

eCTD Document for 32S23

This is an example of the Substance Control of Materials bundle profile. It is to submit Module 3 of CTD 3.2.S.2.3 folder content to the FDA.

eCTD Drug Substance Specification Composition SP4151

Composition SP4151 implementing eCTD 3.2.S.4.1.

eCTD Product Specification Composition SP4151

Composition SP4151 implementing eCTD 3.2.P.5.1.